This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lotan, R. Articles by Zou, C.-P. Search for Related Content PubMed PubMed Citation Articles by Lotan, R. Articles by Zou, C.-P.

Enhanced Efficacy of Combinations of Retinoic Acid- and Retinoid X Receptor-selective Retinoids and -Interferon in Inhibition of Cervical Carcinoma Cell Proliferation¹

Department of Tumor Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030 [R. L., C-C. Z., D. L., C-P. Z.], and Bio-Organic Chemistry Laboratory, SRI International, Menlo Park, California 94025 [M. I. D., L. J.]

Retinoic acid receptors and retinoid X receptors form heterodimers, bind to retinoic acid response elements, and transactivate the transcription of retinoid-responsive genes. Two synthetic retinoids [4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid (TTAB) and 6-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-2-naphthalenecarboxylic acid (TTNN)], which preferentially bind retinoic acid receptors, inhibited the proliferation of cervical carcinoma ME180 cells by 50% at 0.2 nM and 0.2 µM, respectively. In contrast, two other retinoids [2-(4-carboxyphenyl)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1,3-dithiane (SR11203) and 4-(2-methyl-1-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)propenyl)benzoic acid (SR11217)], which preferentially bind retinoic X receptors, inhibited growth by only 12 and 18% at 1 µM, respectively. The combination of suboptimal concentrations of TTAB (0.1 nM) or TTNN (10 nM) with each of the retinoic X receptor-selective retinoids at 1 µM showed more than additive effects on cell proliferation, especially with SR11217. Further increases in proliferation inhibition were observed when IFN- (100 units/ml) was added to these retinoid combinations. Activation of transcription of a reporter gene linked 3' to the retinoic acid receptor ß retinoic acid response element in transiently transfected cells also exhibited additive effects when the cells were treated with combinations of TTAB or TTNN with SR11217. This additive activation of transcription may be the reason why the combination of retinoids is more effective than each retinoid alone. The results also suggest that the use of combinations of retinoids and IFN- may lead to enhanced antitumor effects.

¹ Supported by USPHS Grants P30 CA16672-18 [R. L.] and P01 CA51993 [M. I. D.] from the National Cancer Institute and by the Abell-Hanger Foundation Professorship [R. L.].

² To whom requests for reprints should be addressed, at Department of Tumor Biology, Box 108, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030.

Received 11/15/94. Accepted 11/30/94.

This article has been cited by other articles:

				W. N. Hittelman, D. D. Liu, J. M. Kurie, R. Lotan, J. S. Lee, F. Khuri, H. Ibarguen, R. C. Morice, G. Walsh, J. A. Roth, et al. Proliferative Changes in the Bronchial Epithelium of Former Smokers Treated With Retinoids J Natl Cancer Inst, November 7, 2007; 99(21): 1603 - 1612. [Abstract] [Full Text] [PDF]

				P. Germain, P. Chambon, G. Eichele, R. M. Evans, M. A. Lazar, M. Leid, A. R. De Lera, R. Lotan, D. J. Mangelsdorf, and H. Gronemeyer International Union of Pharmacology. LX. Retinoic Acid Receptors Pharmacol. Rev., December 1, 2006; 58(4): 712 - 725. [Abstract] [Full Text] [PDF]

				F. Bruzzese, E. Di Gennaro, A. Avallone, S. Pepe, C. Arra, M. Caraglia, P. Tagliaferri, and A. Budillon Synergistic Antitumor Activity of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib and IFN-{alpha} in Head and Neck Cancer Cells In vitro and In vivo Clin. Cancer Res., January 15, 2006; 12(2): 617 - 625. [Abstract] [Full Text] [PDF]

				M. T. Ruffin, J. M. Bailey, D. P. Normolle, C. W. Michael, M. E. Bieniasz, D. C. Kmak, E. R. Unger, and D. E. Brenner Low-Dose Topical Delivery of All-Trans Retinoic Acid for Cervical Intraepithelial Neoplasia II and III Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2148 - 2152. [Abstract] [Full Text] [PDF]

				N. Matt, N. B. Ghyselinck, O. Wendling, P. Chambon, and M. Mark Retinoic acid-induced developmental defects are mediated by RAR{beta}/RXR heterodimers in the pharyngeal endoderm Development, May 15, 2003; 130(10): 2083 - 2093. [Abstract] [Full Text] [PDF]

				J. M. Kurie, R. Lotan, J. J. Lee, J. S. Lee, R. C. Morice, D. D. Liu, X.-C. Xu, F. R. Khuri, J. Y. Ro, W. N. Hittelman, et al. Treatment of Former Smokers With 9-cis-Retinoic Acid Reverses Loss of Retinoic Acid Receptor-{beta} Expression in the Bronchial Epithelium: Results From a Randomized Placebo-Controlled Trial J Natl Cancer Inst, February 5, 2003; 95(3): 206 - 214. [Abstract] [Full Text] [PDF]

				R. D. Alvarez, M. G. Conner, H. Weiss, P. M. Klug, S. Niwas, U. Manne, J. Bacus, V. Kagan, K. C. Sexton, C. J. Grubbs, et al. The Efficacy of 9-Cis-Retinoic Acid (Aliretinoin) as a Chemopreventive Agent for Cervical Dysplasia: Results of a Randomized Double-Blind Clinical Trial Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 114 - 119. [Abstract] [Full Text] [PDF]

				T. Seo, D. Lee, Y. S. Shim, J. E. Angell, N. V. Chidambaram, D. V. Kalvakolanu, and J. Choe Viral Interferon Regulatory Factor 1 of Kaposi's Sarcoma-Associated Herpesvirus Interacts with a Cell Death Regulator, GRIM19, and Inhibits Interferon/Retinoic Acid-Induced Cell Death J. Virol., July 29, 2002; 76(17): 8797 - 8807. [Abstract] [Full Text] [PDF]

				X. Guo, D. M Nanus, A. Ruiz, R. R Rando, D. Bok, and L. J Gudas Reduced Levels of Retinyl Esters and Vitamin A in Human Renal Cancers Cancer Res., March 1, 2001; 61(6): 2774 - 2781. [Abstract] [Full Text]

				S.-Y. Sun, P. Yue, L. Mao, M. I. Dawson, B. Shroot, W. W. Lamph, R. A. Heyman, R. A. S. Chandraratna, K. Shudo, W. K. Hong, et al. Identification of Receptor-selective Retinoids That Are Potent Inhibitors of the Growth of Human Head and Neck Squamous Cell Carcinoma Cells Clin. Cancer Res., April 1, 2000; 6(4): 1563 - 1573. [Abstract] [Full Text]

				W. J. Berg, D. M. Nanus, A. Leung, K. T. Brown, B. Hutchinson, M. Mazumdar, X.-C. Xu, R. Lotan, V. E. Reuter, and R. J. Motzer Up-Regulation of Retinoic Acid Receptor {beta} Expression in Renal Cancers in Vivo Correlates with Response to 13-cis-Retinoic Acid and Interferon-{{alpha}}-2a Clin. Cancer Res., July 1, 1999; 5(7): 1671 - 1675. [Abstract] [Full Text] [PDF]

				X.-C. Xu, M. F. Mitchell, E. Silva, A. Jetten, and R. Lotan Decreased Expression of Retinoic Acid Receptors, Transforming Growth Factor {beta}, Involucrin, and Cornifin in Cervical Intraepithelial Neoplasia Clin. Cancer Res., June 1, 1999; 5(6): 1503 - 1508. [Abstract] [Full Text] [PDF]

				F. J. Dilworth, C. Fromental-Ramain, E. Remboutsika, A. Benecke, and P. Chambon Ligand-dependent activation of transcription in vitro by retinoic acid receptor alpha /retinoid X receptor alpha  heterodimers that mimics transactivation by retinoids in vivo PNAS, March 2, 1999; 96(5): 1995 - 2000. [Abstract] [Full Text] [PDF]

				S.-Y. Sun, J. M. Kurie, P. Yue, M. I. Dawson, B. Shroot, R. A. S. Chandraratna, W. K. Hong, and R. Lotan Differential Responses of Normal, Premalignant, and Malignant Human Bronchial Epithelial Cells to Receptor-selective Retinoids Clin. Cancer Res., February 1, 1999; 5(2): 431 - 437. [Abstract] [Full Text] [PDF]

				H. Wan, M. I. Dawson, W. K. Hong, and R. Lotan Overexpressed Activated Retinoid X Receptors Can Mediate Growth Inhibitory Effects of Retinoids in Human Carcinoma Cells J. Biol. Chem., October 9, 1998; 273(41): 26915 - 26922. [Abstract] [Full Text] [PDF]

				B Mascrez, M Mark, A Dierich, N. Ghyselinck, P Kastner, and P Chambon The RXRalpha ligand-dependent activation function 2 (AF-2) is important for mouse development Development, January 12, 1998; 125(23): 4691 - 4707. [Abstract] [PDF]

				E. Guerin, M.-G. Ludwig, P. Basset, and P. Anglard Stromelysin-3 Induction and Interstitial Collagenase Repression by Retinoic Acid. THERAPEUTICAL IMPLICATION OF RECEPTOR-SELECTIVE RETINOIDS DISSOCIATING TRANSACTIVATION AND AP-1-MEDIATED TRANSREPRESSION J. Biol. Chem., April 25, 1997; 272(17): 11088 - 11095. [Abstract] [Full Text] [PDF]

				J. Botling, D. S. Castro, F. Oberg, K. Nilsson, and T. Perlmann Retinoic Acid Receptor/Retinoid X Receptor Heterodimers Can Be Activated through Both Subunits Providing a Basis for Synergistic Transactivation and Cellular Differentiation J. Biol. Chem., April 4, 1997; 272(14): 9443 - 9449. [Abstract] [Full Text] [PDF]

				Y. S. Lopez-Boado, M. Klaus, M. I. Dawson, and C. Lopez-Otin Retinoic Acid-induced Expression of Apolipoprotein D and Concomitant Growth Arrest in Human Breast Cancer Cells Are Mediated through a Retinoic Acid Receptor RARalpha -dependent Signaling Pathway J. Biol. Chem., December 13, 1996; 271(50): 32105 - 32111. [Abstract] [Full Text] [PDF]